Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2024Open Access

Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways

View Full Paper
Ask AI
Bookmark
Share

Authors

TZTing ZhangCLChang LiuNZNing Zhong

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e5b4e9b6db64358754da35https://doi.org/10.20944/preprints202408.1626.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1NMDA Receptor Dysfunction and Cognitive Impairment in Schizophrenia: Mechanisms, Evidence and Therapeutic Potential2025
  2. 2Management of cognitive symptoms in schizophrenia.2024
  3. 3TARGETING THE SIGMA-1/NMDA RECEPTOR COMPLEX TO AMELIORATE COGNITIVE DEFICITS AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA2026
  4. 4Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials2025 · 1 citations
  5. 5Cognitive deficits and functional outcome in schizophrenia2006 · 665 citations